PH25180A - Formulation for preparing sustained release drugs for oral administration - Google Patents

Formulation for preparing sustained release drugs for oral administration

Info

Publication number
PH25180A
PH25180A PH35169A PH35169A PH25180A PH 25180 A PH25180 A PH 25180A PH 35169 A PH35169 A PH 35169A PH 35169 A PH35169 A PH 35169A PH 25180 A PH25180 A PH 25180A
Authority
PH
Philippines
Prior art keywords
formulation
oral administration
sustained release
release drugs
preparing sustained
Prior art date
Application number
PH35169A
Inventor
Massimo Calanchi
Leonardo Gentilini
Luigi Mapelli
Marco Marconi
Original Assignee
Eurand Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Spa filed Critical Eurand Spa
Priority to PH35169A priority Critical patent/PH25180A/en
Publication of PH25180A publication Critical patent/PH25180A/en

Links

PH35169A 1987-04-23 1987-04-23 Formulation for preparing sustained release drugs for oral administration PH25180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH35169A PH25180A (en) 1987-04-23 1987-04-23 Formulation for preparing sustained release drugs for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH35169A PH25180A (en) 1987-04-23 1987-04-23 Formulation for preparing sustained release drugs for oral administration

Publications (1)

Publication Number Publication Date
PH25180A true PH25180A (en) 1991-03-27

Family

ID=19935541

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35169A PH25180A (en) 1987-04-23 1987-04-23 Formulation for preparing sustained release drugs for oral administration

Country Status (1)

Country Link
PH (1) PH25180A (en)

Similar Documents

Publication Publication Date Title
ZA871620B (en) Formulation for preparing sustained release drugs for oral administration
EP0205336A3 (en) Oral sustained release pharmaceutical preparation
AU5087290A (en) Transmembrane formulations for drug administration
AU6893287A (en) Sustained release pharmaceutical preparation
AR243378A1 (en) Sustained release pharmaceutical composition
GR890300058T1 (en) New pharmaceutical preparation for oral use
EP0381194A3 (en) Drug preparation applicable to oral mucosa
FI885460L (en) Method for preparing a pharmaceutical formulation for oral administration with controlled release of the active compound
ZA894020B (en) Controlled release pharmaceutical formulation
IL89868A (en) Pharmaceutical compositions for oral administration, based on diphosphonic acid derivatives
EP0274176A3 (en) Sustained release capsule or tablet formulation
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
AU2228888A (en) Aqueous pharmaceutical preparation for oral administration
IL87219A0 (en) Erythromycin formulations for oral administration
AU2617288A (en) Pharmaceutical formulations for transdermal administration
ZA884878B (en) Substituted benzimidazoles,a process for the preparation thereof,pharmaceutical formulations containing them,and the use thereof
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
AR244243A1 (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
PH25180A (en) Formulation for preparing sustained release drugs for oral administration
ATA264087A (en) PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION
GB8808995D0 (en) Apparatus for oral administration of medicament
IE882232L (en) Erythromycin formulations for oral administration
IL93270A0 (en) Pharmaceutical compositions for oral administration
IE871600L (en) Sustained release pharmaceutical preparation.